Inhibition of BMP-induced ectopic bone formation by an antiangiogenic agent (epigallocatechin 3-gallate).

Connect Tissue Res

Department of Oral Health Science, Graduate School of Dental Medicine, Hokkaido University, N-13, W-7, Kita-ku, Sapporo 060-8586, Japan.

Published: April 2003

Epigallocatechin 3-gallate (EGCG), which is one of the components of green tea, was recently shown to inhibit endothelial cell growth in vitro and angiogenesis in vivo [5]. We have previously shown that bone and cartilage formation by bone morphogenetic protein (BMP) is highly dependent on the geometry of the carrier (vasculature-inducing or -inhibiting geometry [2]. To verify the function of angiogenesis in the BMP induction system, we examine in this article whether inhibition of angiogenesis enhances chondrogenesis and suppresses osteogenesis. Fibrous glass membrane used as a BMP carrier was mixed with 1.2 micrograms rhBMP-2 and 1-10 micrograms of EGCG and was implanted into rats subcutaneously. As the dose of EGCG increased, alkaline phosphatase activity and calcium content were decreased, whereas the type II collagen content was increased. The results clearly indicated that inhibition of vascularization enhanced chondrogenesis and suppressed osteogenesis.

Download full-text PDF

Source
http://dx.doi.org/10.1080/03008200290000772DOI Listing

Publication Analysis

Top Keywords

epigallocatechin 3-gallate
8
inhibition bmp-induced
4
bmp-induced ectopic
4
ectopic bone
4
bone formation
4
formation antiangiogenic
4
antiangiogenic agent
4
agent epigallocatechin
4
3-gallate epigallocatechin
4
3-gallate egcg
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!